Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign‐Born: The <scp>FOCUS</scp>‐<scp>HBV</scp> Multicentre Cohort
Kali Zhou(University of Southern California), Christine Hsu(University of Pennsylvania), Amol S. Rangnekar(Georgetown University), Norah A. Terrault(University of Southern California), Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Ariel Lee(University of Southern California), Jennifer L. Dodge(University of Southern California), Maria Mironova(National Institutes of Health), Christopher K. Wong(University of California, Santa Cruz), Harish Gopalakrishna(National Institute of Diabetes and Digestive and Kidney Diseases), Asif Hitawala(National Institutes of Health), Jaha Norman‐Wheeler(National Institutes of Health), Ariana Chen(University of Michigan), Coleman I. Smith(Georgetown University), James Ajokubi(MedStar Heart & Vascular Institute), Marc G. Ghany(National Institute of Diabetes and Digestive and Kidney Diseases)
Cited by 4
Related Papers
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
|Hepatology|2008|3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k